TACR1 and central nervous system cancer: It is known that SP exerts a mitogenic action in tumor cells [22, 36, 59], and hence, it seems that glioma cells need the stimulus mediated by the neuropeptide, and for this reason cancer cells, including glioma, overexpress the NK-1R [24, 43, 60].